,,,,,,,,,,,Identification,,,,Uniformity of Dosage units by HPLC (by Content Uniformity),,,Assay by HPLC,,Dissolution by HPLC (%) (0.01N; Paddle; 50rpm; 900ml),,Related Substances by HPLC (%m/m),,,,,,,,Microbiological Quality,,,Prepared By Date,Approved By Date
,,,,,,,,,,,,,,,,,,,,,,Tenofovir Disoproxil Fumarate,Emtricitabine,,,,,Any indvidual unspecified impurity,Total impurities,Total aerobic microbial count (CFU/g),Total Yeast and Mould Count (CFU/g),Escherichia coli (in 1g),,
Product Name,Generic Name,Internal Misom No.,Manufacturer Batch No.,Client Name,Specification Ref No,COA No / Rev,Exp. Date,Misom FPS/STP No & Ver,Analytical Method Ref. No,Description,By HPLC,By UV (PDA detector),Indigo carmine aluminium lake,Titanium Dioxide,Tenofovir Disoproxil Fumarate,Emtricitabine,Water Content by KF (% m/m),Tenofovir Disoproxil Fumarate,Emtricitabine,Tenofovir Disoproxil Fumarate,Emtricitabine,Tenofovir Isoproxil Monoester Impurity,5-flurocytosine,5-fluorouracil analog,Sulfoxide isomer - 1,Sulfoxide isomer - 2,Sum of sulfoxide isomers,,,,,,,
,,1,,,,,,,,Complies,,,,,,,,,,,,,,,,,,,,,,,,
,,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,